Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Operating Margin (2016 - 2025)

Medifast (MED) has disclosed Operating Margin for 16 consecutive years, with 10.39% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin fell 1099.0% year-over-year to 10.39%, compared with a TTM value of 3.68% through Dec 2025, down 416.0%, and an annual FY2025 reading of 3.68%, down 416.0% over the prior year.
  • Operating Margin was 10.39% for Q4 2025 at Medifast, down from 4.56% in the prior quarter.
  • Across five years, Operating Margin topped out at 15.58% in Q2 2021 and bottomed at 10.39% in Q4 2025.
  • Average Operating Margin over 5 years is 6.57%, with a median of 10.23% recorded in 2022.
  • The sharpest move saw Operating Margin crashed -1774bps in 2024, then soared 366bps in 2025.
  • Year by year, Operating Margin stood at 12.4% in 2021, then fell by -22bps to 9.67% in 2022, then tumbled by -53bps to 4.54% in 2023, then plummeted by -87bps to 0.6% in 2024, then tumbled by -1844bps to 10.39% in 2025.
  • Business Quant data shows Operating Margin for MED at 10.39% in Q4 2025, 4.56% in Q3 2025, and 1.01% in Q2 2025.